Kenneth L Londoner – The Changing Role of a MedTech CEO

Kenneth L Londoner is the founder and CEO of BioSig Technologies, Inc., a position he has held since 2009. Londoner is responsible for overseeing the operations of the company that develops and brings to market a proprietary biomedical signal processing platform designed to improve the electrophysiology (EP) marketplace.

This dynamic and experienced executive often discusses the lessons he has learned and the experiences he has accumulated over his extensive and current medical technology career. In this article, Londoner explores the emerging trends in the medical technology sector and how leadership will need to change in order to take advantage of those trends.

All firms have room to improve their hiring strategies, but medical technology companies are especially vulnerable now with an increasingly tight talent pool. As new technologies come on the scene, particularly disruptive digital technologies, leaders will need to be even more dynamic and adaptive in their approach. Besides a strong leadership profile, medical technology industry CEOs need to demonstrate verifiable success in leading comparable organizations though several business cycles.

The role of a CEO at a med tech company changes dramatically as the company grows. The skills and experience needed at the preclinical and developmental stages, translating vision into strategy and finding capital are vastly different to those required during the newly and fully commercial stages of scaling a company and building a brand. Nowadays, across the life sciences and health care industry, stakeholders are looking at how virtual and digital health, and access to real-time data, will impact clinical practices and ultimately lower health care costs.

As a head officer of BioSig Technologies, Kenneth L Londoner is devoting his energy and passion to improve the lives of patients, with the aim of improving minimally invasive treatments. Londoner is also working with Lafayette College to develop and expand a summer internship program designed to provide undergraduate students with high value summer employment in leading growth industries. Prior to establishing BioSig Technologies in 2009, Londoner had an over two decade’s long investment career at a leading institutional money management firm. He has a Bachelor’s Degree in economics and finance from Lafayette College and MBA from NYU's Stern School of Business.